Home>Publications>Cost comparison analysis of recurrent clostridium difficile treated with fecal microbiota transplants versus antimicrobial therapy
Shah S, Rascati K, Chimah (Kanu) C, Shukla N. Cost comparison analysis of recurrent clostridium difficile treated with fecal microbiota transplants versus antimicrobial therapy. Poster presented at the 2017 Academy of Managed Care Pharmacy Conference; March 2017. Denver, CO. [abstract] J Manag Care Spec Pharm. 2017 Mar; 23(3a):S3.
Abstract not available at this time.
RTI Health Solutions®
The power of knowledge. The value of understanding.
Steeped in a tradition of rigor and process, we maintain a legacy of setting the scientific standards within our industry. We employ the right approaches and proven research practices to analyze evidence and draw meaningful insights. Our uncompromisingly ethical and objective researchers ensure that results will hold up to scrutiny and reveal the benefits, risks, value and potential of your products. Learn more.